A Biological Basis of Therapy for Negative Symptom Spectrum Disorders: Risperdal Effect on Frontal Metabolism in Asperger's Disorder
Phase of Trial: Phase IV
Latest Information Update: 17 Aug 2016
At a glance
- Drugs Risperidone (Primary)
- Indications Asperger syndrome
- Focus Biomarker; Therapeutic Use
- 19 Jul 2011 Actual end date (1 Sep 2008) added as reported by ClinicalTrials.gov.
- 19 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Nov 2006 New trial record.